By G HossainPosted on August 18, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs With demand for pharma services historically lagging changes in biotech funding, analysts expect CDMOs to experience an uptick in activity in late 2026 or early 2027. Rebounding biotech funds expected to spur CDMO growth within year Post navigation Assessing shared failures with AI is key to cell and gene therapy’s evolutionLEO adds to dermatology portfolio with $435M deal for late-stage rare disease drug